Comment to FDA on Modified Risk Tobacco Product Application

Commentary

Comment to FDA on Modified Risk Tobacco Product Application

The MRTP pathway is critically important toward reducing the toll of smoking on the U.S. population.

Re: Docket No. FDA-2017-D-3001

Modified Risk Tobacco Product (MRTP) for IQOS System, 82 Fed. Reg. 27487